Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials

Gary A Rosenberg; Jillian Prestopnik; John C Adair; Branko N Huisa; Janice Knoefel; Arvind Caprihan; Charles Gasparovic; Jeffrey Thompson; Erik B Erhardt; Ronald Schrader

doi:10.1136/jnnp-2014-309421

Article info

Cerebrovascular disease

Research paper

Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials

Authors

Gary A Rosenberg Department of Neurology, University of New Mexico, Albuquerque, New Mexico, USA Department of Neurosciences, University of New Mexico, Albuquerque, New Mexico, USA Department of Cell Biology and Physiology, University of New Mexico, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
Jillian Prestopnik Department of Neurology, University of New Mexico, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
John C Adair Department of Neurology, University of New Mexico, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
Branko N Huisa Department of Neurology, University of New Mexico, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
Janice Knoefel Department of Geriatrics, University of New Mexico, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
Arvind Caprihan The MIND Research Network, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
Charles Gasparovic The MIND Research Network, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
Jeffrey Thompson Department of Neurology, University of New Mexico, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
Erik B Erhardt Department of Mathematics and Statistics, University of New Mexico, Albuquerque, New Mexico, USA PubMed articles Google scholar articles
Ronald Schrader Clinical and Translational Science Center, Albuquerque, New Mexico, USA PubMed articles Google scholar articles

Correspondence to Dr Gary Rosenberg, Department of Neurology, Health Sciences Center, MSC 10 5620, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA; grosenberg{at}salud.unm.edu

View Full Text

Citation

Rosenberg GA, Prestopnik J, Adair JC, et al

Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials

Journal of Neurology, Neurosurgery & Psychiatry 2015;86:1324-1330.

Publication history

Received September 4, 2014
Revised December 8, 2014
Accepted January 4, 2015
First published January 24, 2015.

Online issue publication

April 13, 2016

Article Versions

Previous version (13 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password